Skip to main content
OpenTrials

Clinical trial condition

Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)

Explore clinical trials studying Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) trial results

Completed

ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)

NCT02319005

Conditions
Alzheimer Disease, Amyloid Neuropathies, Amyloid Neuropathies, Familial, +27 more
Locations
  • Clinical Trial Site Bakersfield, California, United States
  • Clinical Trial Site Beverly Hills, California, United States
  • Clinical Trial Site La Mesa, California, United States
  • Clinical Trial Site Los Angeles, California, United States
View all 61 locations
View Trial Details

Related conditions